David Hille

Partner, New York

Biography

David Hille is a senior partner known for his sophisticated practice in complex commercial litigation and in international arbitration proceedings. He is described by clients as “smart, sophisticated, effective, professional and charismatic. A tremendous talent.” (Chambers USA 2024). He is also described as “always available, very calm and very unruffled. He’s fantastic.” (Chambers USA 2023). David is also recognized in Who’s Who Legal – Commercial Litigation 2023 as a leading practitioner.

Overview

David is the Co-Chair of the Firm's Global Commercial Litigation Practice. He handles disputes on behalf of international clients in cases involving complex contracts, business torts, intellectual property, award and judgment enforcement, and class actions in courts throughout the US. He also has significant international and domestic arbitration experience and represents sovereign and other clients in an array of proceedings, including those conducted under AAA, FINRA, ICDR, UNCITRAL, ICSID, ICC, SIAC and CPR rules.

Notable clients benefiting from David's knowledge and experience include global life sciences/pharmaceutical companies, numerous clients in the energy sector, financial institutions, national and provincial governments, and sovereign wealth funds. He also has experience in helping high net worth individuals in a variety of sensitive matters.

David previously served as the head of the Firm's Disputes Section for the Americas and served two terms on the global Partnership Committee, the Firm's eight member, elected governance body.

Bars and Courts
New York
US District Court for the Eastern District of New York
US District Court for the Southern District of New York
US District Court for the District of Columbia
US Court of Appeals for the District of Columbia Circuit
US Court of Appeals for the Second Circuit
US Court of Appeals for the Sixth Circuit
Education
JD
University of Notre Dame
BS
Clemson University
Languages
English

Experience

Select matter representations include:

Pharma/Life Sciences

  • Pfizer in a breach of contract case in Federal Court in Delaware
  • Novartis in a breach of contract and fraud case in Federal Court in New York
  • Alkermes in a CPR arbitration involving termination of a long-term collaboration and license agreement
  • A global pharmaceutical company in disputes with CMO suppliers

Energy

  • An international energy company in securities and consumer class actions
  • A global renewables company in a breach of contract and fraud case in the Delaware Chancery Court
  • A Canadian Province in UNCITRAL arbitration proceedings regarding natural gas royalty calculations
  • A global construction and engineering firm in a RICO action
  • A petrochemical company in international litigation regarding an ethane joint venture
  • A worldwide manufacturer of gas turbines in an ICDR arbitration

Financial

  • Two international banks in a trial of fraudulent transfer claims in New York
  • A U.S. financial institution in multiple FINRA arbitrations
  • A group of Chinese banks in contempt proceedings in Federal Court

Sovereign/International

  • A national government in two ICSID arbitration proceedings
  • Sovereign wealth funds in a variety of international disputes
  • A global consumer electronics company in a SIAC arbitration and related U.S. litigation